<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Creatine During Pregnancy: Current Research and Unknowns</title>
  <meta name="description" content="Current research on creatine supplementation during pregnancy. Animal studies show fetal neuroprotection potential. Human evidence is insufficient for...">
  <meta name="robots" content="index, follow">
  <link rel="canonical" href="https://creatinepedia.com/safety/creatine-during-pregnancy">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://creatinepedia.com/safety/creatine-during-pregnancy">
  <meta property="og:title" content="Creatine During Pregnancy: Current Research and Unknowns">
  <meta property="og:description" content="Current research on creatine supplementation during pregnancy. Animal studies show fetal neuroprotection potential. Human evidence is insufficient for...">
  <meta property="og:site_name" content="Creatinepedia">
  <meta name="twitter:card" content="summary_large_image">
  <meta name="twitter:title" content="Creatine During Pregnancy: Current Research and Unknowns">
  <meta name="twitter:description" content="Current research on creatine supplementation during pregnancy. Animal studies show fetal neuroprotection potential. Human evidence is insufficient for...">
  <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><rect fill='%230f172a' width='100' height='100' rx='12'/><text x='50' y='68' font-family='monospace' font-size='40' fill='%230284c7' text-anchor='middle'>Cr</text></svg>">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=DM+Sans:wght@400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
  <script src="https://cdn.tailwindcss.com"></script>
  <script>
    tailwind.config = {
      darkMode: 'class',
      theme: {
        extend: {
          fontFamily: {
            sans: ['DM Sans', 'system-ui', 'sans-serif'],
            serif: ['Instrument Serif', 'Georgia', 'serif'],
          },
          colors: {
            slate: { 925: '#0c0f14', 950: '#090b10' }
          }
        }
      }
    }
  </script>
  <style>
    ::selection { background: rgba(2, 132, 199, 0.3); }
    ::-webkit-scrollbar { width: 8px; }
    ::-webkit-scrollbar-track { background: var(--bg-secondary, #18181b); }
    ::-webkit-scrollbar-thumb { background: var(--border, #27272a); border-radius: 4px; }
    ::-webkit-scrollbar-thumb:hover { background: #3f3f46; }

    /* Article body — light mode */
    .article-body { max-width: 720px; margin: 0 auto; padding: 0 1rem; }
    .article-body h1 { font-family: 'Instrument Serif', Georgia, serif; font-size: 2.75rem; line-height: 1.15; margin-bottom: 1rem; color: #0f172a; }
    .article-body h2 { font-family: 'Instrument Serif', Georgia, serif; font-size: 1.875rem; margin: 2.5rem 0 1rem; color: #0f172a; }
    .article-body h3 { font-size: 1.25rem; font-weight: 600; margin: 2rem 0 0.75rem; color: #0f172a; }
    .article-body p { margin-bottom: 1.5rem; color: #475569; line-height: 1.8; }
    .article-body a { color: #0284c7; text-decoration: none; }
    .article-body a:hover { text-decoration: underline; }
    .article-body ul, .article-body ol { margin: 1.5rem 0; padding-left: 1.5rem; color: #475569; }
    .article-body li { margin-bottom: 0.75rem; line-height: 1.7; }
    .article-body strong { color: #1e293b; }
    .article-body blockquote { border-left: 3px solid #0284c7; padding-left: 1.5rem; margin: 2rem 0; font-style: italic; color: #334155; }
    .article-body .meta { color: #64748b; font-size: 0.9rem; margin-bottom: 2rem; }
    .article-body table { width: 100%; border-collapse: collapse; margin: 2rem 0; }
    .article-body th, .article-body td { text-align: left; padding: 0.75rem 1rem; border-bottom: 1px solid #e2e8f0; color: #475569; }
    .article-body th { color: #0f172a; font-weight: 600; border-bottom: 2px solid #cbd5e1; }
    .article-body .cta-box {
      background: linear-gradient(135deg, rgba(2, 132, 199, 0.08), rgba(13, 148, 136, 0.04));
      border: 1px solid rgba(2, 132, 199, 0.2);
      border-radius: 16px; padding: 2.5rem; margin: 3rem 0; text-align: center;
    }
    .article-body .cta-box h3 { margin-top: 0; font-family: 'Instrument Serif', Georgia, serif; font-size: 1.5rem; }
    .article-body .cta-box p { color: #64748b; margin-bottom: 1.5rem; }
    .article-body .cta-button {
      display: inline-block; background: #0284c7; color: #ffffff;
      padding: 1rem 2rem; border-radius: 8px; font-weight: 600;
      text-decoration: none; transition: background 0.2s;
    }
    .article-body .cta-button:hover { background: #0ea5e9; text-decoration: none; }
    .article-body .related-articles { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .related-articles h3 { margin-bottom: 1rem; }
    .article-body .related-articles ul { list-style: none; padding: 0; }
    .article-body .related-articles li { margin-bottom: 0.5rem; }
    .article-body .faq-section { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .faq-section > h2 { margin-top: 0; }
    .article-body .faq-item { margin-bottom: 2rem; }
    .article-body .faq-item h3 { color: #0f172a; margin-bottom: 0.5rem; }
    .article-body .faq-item p { margin-bottom: 0; }

    /* Article body — dark mode */
    .dark .article-body h1, .dark .article-body h2, .dark .article-body h3 { color: #fafaf9; }
    .dark .article-body p { color: #a1a1aa; }
    .dark .article-body ul, .dark .article-body ol { color: #a1a1aa; }
    .dark .article-body strong { color: #e4e4e7; }
    .dark .article-body a { color: #38bdf8; }
    .dark .article-body blockquote { color: #d4d4d8; }
    .dark .article-body .meta { color: #71717a; }
    .dark .article-body th, .dark .article-body td { border-bottom-color: #27272a; color: #a1a1aa; }
    .dark .article-body th { color: #fafaf9; border-bottom-color: #3f3f46; }
    .dark .article-body .cta-box { background: linear-gradient(135deg, rgba(2, 132, 199, 0.12), rgba(13, 148, 136, 0.06)); }
    .dark .article-body .cta-box p { color: #a1a1aa; }
    .dark .article-body .related-articles { border-top-color: #27272a; }
    .dark .article-body .faq-section { border-top-color: #27272a; }
    .dark .article-body .faq-item h3 { color: #fafaf9; }

    /* Newsletter section */
    #newsletter input::placeholder { color: #94a3b8; }
    .dark #newsletter input::placeholder { color: #52525b; }


    /* Mega menu */
    .mega-panel { transition: opacity 0.15s ease, visibility 0.15s ease; }
    .mega-panel.hidden { opacity: 0; visibility: hidden; display: none; }
    .mega-panel:not(.hidden) { opacity: 1; visibility: visible; display: block; }
    .mega-link {
      display: block; padding: 6px 0;
      font-size: 0.875rem; color: #475569;
      transition: color 0.15s;
    }
    .mega-link:hover { color: #0f172a; text-decoration: none; }
    .dark .mega-link { color: #a1a1aa; }
    .dark .mega-link:hover { color: #fafaf9; }
    .mega-view-all {
      display: inline-block; margin-top: 12px;
      font-size: 0.8125rem; font-weight: 500;
      color: #0284c7; transition: color 0.15s;
    }
    .mega-view-all:hover { color: #0ea5e9; text-decoration: none; }
    .dark .mega-view-all { color: #38bdf8; }
    .dark .mega-view-all:hover { color: #7dd3fc; }

    /* Nav effects */
    .nav-link { position: relative; }
    .nav-link::after {
      content: ''; position: absolute; bottom: -2px; left: 0;
      width: 0; height: 1px; background: #0284c7; transition: width 0.3s ease;
    }
    .nav-link:hover::after { width: 100%; }
    .cta-glow { position: relative; }
    .cta-glow::before {
      content: ''; position: absolute; inset: -2px;
      background: linear-gradient(135deg, #0284c7, #0891b2);
      border-radius: inherit; opacity: 0; filter: blur(12px);
      transition: opacity 0.3s ease; z-index: -1;
    }
    .cta-glow:hover::before { opacity: 0.4; }

    /* Active trigger state */
    .mega-trigger[aria-expanded="true"] { color: #0f172a; }
    .dark .mega-trigger[aria-expanded="true"] { color: #fafaf9; }
    .mega-trigger[aria-expanded="true"] svg { transform: rotate(180deg); }


    @media (max-width: 768px) {
      .article-body h1 { font-size: 2rem; }
      .article-body h2 { font-size: 1.5rem; }
    }
  </style>
  <script type="application/ld+json">
  {
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Why Creatine Matters During Fetal Development?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The developing fetus has high energy demands, and the creatine-phosphocreatine system plays an important role in fetal metabolism. Creatine is synthesized by the fetus, but fetal synthesis capacity is limited, particularly in early development. The placenta transfers creatine from maternal blood to the fetus, supplementing fetal production."
      }
    },
    {
      "@type": "Question",
      "name": "What is the ellery et al. research program?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Stacey Ellery and colleagues at the Hudson Institute of Medical Research in Melbourne, Australia, have led the investigation into creatine and pregnancy. Their research program has progressed from animal models to human observational studies and early clinical work."
      }
    },
    {
      "@type": "Question",
      "name": "What is the dickinson et al. preclinical data?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Dickinson et al. (2014) published preclinical research examining the mechanisms of creatine-mediated neuroprotection in fetal development. Their work, published in the Journal of Clinical and Experimental Pharmacology and Physiology, examined creatine supplementation in animal models of birth asphyxia and demonstrated protective effects on multiple organ systems, not only the brain."
      }
    },
    {
      "@type": "Question",
      "name": "What is the human observational data?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Observational studies have examined creatine levels in pregnant women and their relationship to pregnancy outcomes. Lower maternal creatine levels have been associated with lower birth weight in some studies. The fetal capacity for creatine synthesis increases throughout gestation but remains limited relative to postnatal capacity, suggesting that maternal supply is physiologically important during pregnancy."
      }
    },
    {
      "@type": "Question",
      "name": "What is the current state of human trials?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "As of this writing, human clinical trials of creatine supplementation during pregnancy are in early stages. The transition from animal models to human trials requires establishing safety in the pregnant population before efficacy can be assessed. This process is appropriately cautious, as any intervention during pregnancy carries potential risks to both mother and fetus that must be thoroughly evaluated."
      }
    }
  ]
}
  </script>
</head>
<body class="bg-slate-50 dark:bg-slate-950 font-sans antialiased">

  <nav class="fixed top-0 left-0 right-0 z-50 border-b border-slate-200 dark:border-zinc-800/60 bg-white/90 dark:bg-slate-950/90 backdrop-blur-md">
    <div class="max-w-7xl mx-auto">
      <div class="flex items-center justify-between h-16 px-6">
        <!-- Logo -->
        <a href="/" class="flex items-center gap-3 group">
          <div class="w-8 h-8 rounded-md bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center group-hover:border-sky-500/50 transition-colors">
            <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
          </div>
          <span class="text-slate-500 dark:text-zinc-400 text-sm tracking-tight">
            <span class="text-slate-800 dark:text-zinc-200 font-medium">Creatine</span><span class="text-sky-600 dark:text-sky-400">pedia</span>
          </span>
        </a>

        <!-- Desktop Nav -->
        <div class="hidden lg:flex items-center gap-1">

          <!-- Science dropdown -->
          <div class="relative" data-mega="science">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Research
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- Applications dropdown -->
          <div class="relative" data-mega="applications">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Applications
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- All Articles link -->
          <a href="/articles" class="nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors">All Articles</a>

          <div class="w-px h-4 bg-slate-300 dark:bg-zinc-800 mx-2"></div>

          <!-- CTA -->
          <a href="#newsletter" class="px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors cta-glow">New Entries</a>
        </div>

        <!-- Mobile menu button -->
        <button id="mobile-menu-btn" class="lg:hidden p-2 text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200">
          <svg id="menu-icon" class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
          <svg id="close-icon" class="w-5 h-5 hidden" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"></path></svg>
        </button>
      </div>

      <!-- ═══ MEGA PANEL: Research ═══ -->
      <div id="mega-science" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-3 gap-8">
            <!-- Column 1: Science -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Science & Mechanisms</span>
              </div>
              <div class="space-y-1">
                <a href="/science/what-is-creatine-monohydrate" class="mega-link">What Is Creatine Monohydrate?</a>
                <a href="/science/how-creatine-works-in-the-body" class="mega-link">How Creatine Works</a>
                <a href="/science/creatine-atp-resynthesis" class="mega-link">ATP Resynthesis</a>
                <a href="/science/creatine-and-muscle-growth" class="mega-link">Muscle Growth Research</a>
                <a href="/science/creatine-and-brain-function" class="mega-link">Brain Function</a>
                <a href="/science/creatine-and-aging" class="mega-link">Aging & Sarcopenia</a>
              </div>
              <a href="/science" class="mega-view-all">All 20 articles &rarr;</a>
            </div>

            <!-- Column 2: Dosing & Safety -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-teal-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12h6m-6 4h6m2 5H7a2 2 0 01-2-2V5a2 2 0 012-2h5.586a1 1 0 01.707.293l5.414 5.414a1 1 0 01.293.707V19a2 2 0 01-2 2z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Dosing & Safety</span>
              </div>
              <div class="space-y-1">
                <a href="/dosing/creatine-loading-protocol" class="mega-link">Loading Protocol</a>
                <a href="/dosing/creatine-maintenance-dose" class="mega-link">Maintenance Dosing</a>
                <a href="/dosing/creatine-timing-before-or-after-workout" class="mega-link">Timing: Before or After?</a>
                <a href="/safety/is-creatine-safe" class="mega-link">Is Creatine Safe?</a>
                <a href="/safety/creatine-and-kidneys" class="mega-link">Kidney Health</a>
                <a href="/safety/creatine-and-hair-loss" class="mega-link">Hair Loss Myth</a>
              </div>
              <a href="/dosing" class="mega-view-all">Dosing (15) &rarr;</a>
              <span class="mx-2 text-slate-300 dark:text-zinc-700">|</span>
              <a href="/safety" class="mega-view-all">Safety (15) &rarr;</a>
            </div>

            <!-- Column 3: CTA Card -->
            <div class="bg-gradient-to-br from-sky-500/10 to-teal-500/5 dark:from-sky-500/15 dark:to-teal-500/5 border border-sky-500/20 rounded-xl p-6 flex flex-col justify-between">
              <div>
                <h3 class="text-lg font-semibold text-slate-900 dark:text-zinc-100 mb-2">The Creatine Encyclopedia</h3>
                <p class="text-sm text-slate-600 dark:text-zinc-400 mb-4">100 entries. Every claim cited from peer-reviewed sources. No marketing. No supplement sales.</p>
              </div>
              <a href="/science/creatine-mechanisms-summary" class="inline-flex items-center justify-center px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg text-sm transition-colors cta-glow">
                Start Reading
              </a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ MEGA PANEL: Applications ═══ -->
      <div id="mega-applications" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-4 gap-8">
            <!-- Column 1: By Sport -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-amber-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 10V3L4 14h7v7l9-11h-7z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">By Sport</span>
              </div>
              <div class="space-y-1">
                <a href="/sports/creatine-for-powerlifting" class="mega-link">Powerlifting</a>
                <a href="/sports/creatine-for-bodybuilding" class="mega-link">Bodybuilding</a>
                <a href="/sports/creatine-for-crossfit" class="mega-link">CrossFit</a>
                <a href="/sports/creatine-for-mma" class="mega-link">MMA & Combat Sports</a>
                <a href="/sports/creatine-for-soccer" class="mega-link">Soccer</a>
                <a href="/sports/creatine-for-swimming" class="mega-link">Swimming</a>
              </div>
              <a href="/sports" class="mega-view-all">All 20 sports &rarr;</a>
            </div>

            <!-- Column 2: Comparisons -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-violet-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M8 7h12m0 0l-4-4m4 4l-4 4m0 6H4m0 0l4 4m-4-4l4-4"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">vs Other Supplements</span>
              </div>
              <div class="space-y-1">
                <a href="/comparisons/creatine-vs-protein-powder" class="mega-link">vs Protein Powder</a>
                <a href="/comparisons/creatine-vs-bcaa" class="mega-link">vs BCAAs</a>
                <a href="/comparisons/creatine-vs-beta-alanine" class="mega-link">vs Beta-Alanine</a>
                <a href="/comparisons/creatine-vs-pre-workout" class="mega-link">vs Pre-Workout</a>
                <a href="/comparisons/creatine-vs-ashwagandha" class="mega-link">vs Ashwagandha</a>
              </div>
              <a href="/comparisons" class="mega-view-all">All 15 comparisons &rarr;</a>
            </div>

            <!-- Column 3: Product Quality -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-emerald-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5.618-4.016A11.955 11.955 0 0112 2.944a11.955 11.955 0 01-8.618 3.04A12.02 12.02 0 003 9c0 5.591 3.824 10.29 9 11.622 5.176-1.332 9-6.03 9-11.622 0-1.042-.133-2.052-.382-3.016z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Product Quality</span>
              </div>
              <div class="space-y-1">
                <a href="/quality/creatine-monohydrate-vs-hcl" class="mega-link">Monohydrate vs HCl</a>
                <a href="/quality/creatine-forms-comparison" class="mega-link">All Forms Compared</a>
                <a href="/quality/third-party-testing-creatine" class="mega-link">Third-Party Testing</a>
                <a href="/quality/creapure-vs-generic-creatine" class="mega-link">Creapure vs Generic</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/quality" class="mega-view-all">All 15 guides &rarr;</a>
            </div>

            <!-- Column 4: Quick Links -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 7h8m0 0v8m0-8l-8 8-4-4-6 6"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Quick Links</span>
              </div>
              <div class="space-y-1">
                <a href="/science/creatine-mechanisms-summary" class="mega-link">Complete Science Guide</a>
                <a href="/dosing/creatine-dosing-protocols-summary" class="mega-link">Complete Dosing Guide</a>
                <a href="/safety/creatine-safety-complete-guide" class="mega-link">Complete Safety Guide</a>
                <a href="/sports/creatine-for-sport-summary" class="mega-link">Every Sport Guide</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/articles" class="mega-view-all">All 100 articles &rarr;</a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ Mobile Menu ═══ -->
      <div id="mobile-menu" class="hidden lg:hidden border-t border-slate-200 dark:border-zinc-800 bg-white dark:bg-slate-950 max-h-[80vh] overflow-y-auto">
        <div class="px-6 py-4 space-y-1">
          <!-- Research -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Research
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Science</p>
            <a href="/science/what-is-creatine-monohydrate" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">What Is Creatine?</a>
            <a href="/science/how-creatine-works-in-the-body" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">How Creatine Works</a>
            <a href="/science" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Dosing</p>
            <a href="/dosing/creatine-loading-protocol" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Loading Protocol</a>
            <a href="/dosing/creatine-maintenance-dose" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Maintenance Dose</a>
            <a href="/dosing" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Safety</p>
            <a href="/safety/is-creatine-safe" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Is Creatine Safe?</a>
            <a href="/safety/creatine-and-kidneys" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Kidney Health</a>
            <a href="/safety" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
          </div>

          <!-- Applications -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Applications
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Sports</p>
            <a href="/sports/creatine-for-powerlifting" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Powerlifting</a>
            <a href="/sports/creatine-for-bodybuilding" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Bodybuilding</a>
            <a href="/sports" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 sports &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Comparisons</p>
            <a href="/comparisons/creatine-vs-protein-powder" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs Protein Powder</a>
            <a href="/comparisons/creatine-vs-bcaa" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs BCAAs</a>
            <a href="/comparisons" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 comparisons &rarr;</a>
          </div>

          <!-- Direct links -->
          <a href="/articles" class="block py-3 text-slate-800 dark:text-zinc-200 font-medium">All Articles</a>

          <!-- CTA -->
          <a href="#newsletter" class="block mt-4 py-3 bg-sky-600 text-white text-center font-semibold rounded-lg">Get New Entries</a>
        </div>
      </div>
    </div>
  </nav>

  <main class="pt-24 pb-16">
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mb-6">
      <div class="flex items-center gap-2 text-sm">
        <a href="/" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Home</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/articles" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Articles</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/safety" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Safety & Concerns</a>
      </div>
    </div>
    <div class="article-body">
      <article>
    <h1>Creatine During Pregnancy: Current Research and Unknowns</h1>

    <p>Creatine supplementation during pregnancy represents one of the genuinely uncertain areas in creatine research. Unlike kidney function or hair loss, where the evidence clearly supports safety, the pregnancy question involves a population that is largely excluded from supplement trials for ethical reasons. The research that does exist is provocative: animal studies suggest that maternal creatine supplementation may protect the developing fetal brain from birth-related oxygen deprivation. But translating animal findings to human recommendations requires human trials that are only beginning to emerge.</p>

    <h2>Why Creatine Matters During Fetal Development</h2>

    <p>The developing fetus has high energy demands, and the creatine-phosphocreatine system plays an important role in fetal metabolism. Creatine is synthesized by the fetus, but fetal synthesis capacity is limited, particularly in early development. The placenta transfers creatine from maternal blood to the fetus, supplementing fetal production.</p>

    <p>During labor and delivery, the fetus may experience periods of reduced oxygen supply (hypoxia). The phosphocreatine system serves as an energy reserve that can buffer ATP demand during these hypoxic episodes, maintaining cellular function until oxygen supply is restored. A fetus with higher phosphocreatine reserves may be better equipped to tolerate birth-related hypoxia without sustaining organ damage, particularly brain injury.</p>

    <p>This biological rationale has made maternal creatine supplementation a subject of serious investigation in perinatal medicine, primarily through the work of researchers in Australia.</p>

    <h2>The Ellery et al. Research Program</h2>

    <p>Stacey Ellery and colleagues at the Hudson Institute of Medical Research in Melbourne, Australia, have led the investigation into creatine and pregnancy. Their research program has progressed from animal models to human observational studies and early clinical work.</p>

    <p>Ellery et al. (2020), publishing in <em>Nutrients</em>, provided a comprehensive review of the evidence for creatine as a potential intervention for fetal neuroprotection. Their review summarized the preclinical data, the biological rationale, and the current state of human research. Key findings from their review included evidence from animal models showing that maternal creatine supplementation reduced brain injury in offspring subjected to birth asphyxia, evidence that creatine crosses the placenta and contributes to fetal creatine pools, and the identification of a need for human clinical trials to establish safety and efficacy in pregnant populations.</p>

    <p>The animal data is compelling. In spiny mouse models (chosen because their placental structure resembles human placentation), maternal creatine supplementation prior to induced birth asphyxia resulted in significantly less brain injury in offspring compared to non-supplemented controls. The protective effect was attributed to enhanced phosphocreatine reserves in the fetal brain, which maintained ATP levels during oxygen deprivation.</p>

    <h2>The Dickinson et al. Preclinical Data</h2>

    <p>Dickinson et al. (2014) published preclinical research examining the mechanisms of creatine-mediated neuroprotection in fetal development. Their work, published in the <em>Journal of Clinical and Experimental Pharmacology and Physiology</em>, examined creatine supplementation in animal models of birth asphyxia and demonstrated protective effects on multiple organ systems, not only the brain.</p>

    <p>The protective effects extended to the diaphragm (respiratory function), kidneys, and other organs vulnerable to hypoxic-ischemic injury during complicated deliveries. This multi-organ protection is consistent with the role of phosphocreatine as a universal energy buffer: any organ with high energy demands can benefit from enhanced creatine stores during periods of compromised oxygen supply.</p>

    <h2>Human Observational Data</h2>

    <p>Observational studies have examined creatine levels in pregnant women and their relationship to pregnancy outcomes. Lower maternal creatine levels have been associated with lower birth weight in some studies. The fetal capacity for creatine synthesis increases throughout gestation but remains limited relative to postnatal capacity, suggesting that maternal supply is physiologically important during pregnancy.</p>

    <p>Dietary creatine intake during pregnancy varies widely and depends on meat consumption. Vegetarian and vegan pregnant women have lower creatine intake from diet and may have lower creatine stores. Whether this dietary variation translates to differences in fetal outcomes is an active area of investigation.</p>

    <h2>Current State of Human Trials</h2>

    <p>As of this writing, human clinical trials of creatine supplementation during pregnancy are in early stages. The transition from animal models to human trials requires establishing safety in the pregnant population before efficacy can be assessed. This process is appropriately cautious, as any intervention during pregnancy carries potential risks to both mother and fetus that must be thoroughly evaluated.</p>

    <p>The safety profile of creatine in non-pregnant populations is reassuring. Creatine is an endogenous compound already present in the body, synthesized naturally, and obtained through dietary sources. It is not a xenobiotic or pharmaceutical. These characteristics support its biological plausibility as a safe intervention during pregnancy, but plausibility is not evidence. Human pregnancy safety data is needed.</p>

    <h2>What We Do Not Know</h2>

    <p>Several critical questions remain unanswered:</p>

    <p><strong>Dosing during pregnancy.</strong> The optimal dose of creatine for maternal-fetal benefit has not been established in humans. The standard 3-5 g/day maintenance dose used in athletic populations may or may not be appropriate during pregnancy. Maternal physiology, blood volume expansion, renal function changes, and placental transfer dynamics all affect how creatine is distributed and metabolized during pregnancy.</p>

    <p><strong>Timing.</strong> When during pregnancy creatine supplementation should begin and end has not been determined. The fetal neuroprotection hypothesis suggests that supplementation in late pregnancy (when the risk of birth complications is highest) would be most relevant. However, creatine stores take weeks to saturate, so earlier initiation might be necessary to ensure adequate fetal reserves at delivery.</p>

    <p><strong>Safety for the developing fetus.</strong> While animal studies have shown no adverse effects on fetal development from maternal creatine supplementation, human fetal safety data is limited. The developing human brain, endocrine system, and other organs may respond differently than animal models.</p>

    <p><strong>Interactions with pregnancy complications.</strong> How creatine supplementation interacts with gestational diabetes, preeclampsia, intrauterine growth restriction, and other pregnancy complications is unknown. These conditions alter maternal metabolism in ways that could affect creatine dynamics.</p>

    <h2>Current Recommendations</h2>

    <p>No major medical organization currently recommends creatine supplementation during pregnancy. This is not because evidence suggests it is harmful. It is because insufficient evidence exists to make a positive recommendation. The standard of evidence for recommending interventions during pregnancy is appropriately higher than for the general population.</p>

    <p>Women who were taking creatine before becoming pregnant face a practical decision. Stopping supplementation poses no known risk to the pregnancy (creatine stores naturally deplete over 4-6 weeks). Continuing supplementation means using a supplement that has not been specifically evaluated for pregnancy safety in human trials, even though the available evidence does not suggest harm.</p>

    <p>This decision should be made in consultation with an obstetrician or maternal-fetal medicine specialist. The physician can weigh the individual patient's risk profile, the available evidence, and the patient's comfort with uncertainty.</p>

    <h2>Breastfeeding</h2>

    <p>Creatine is present in breast milk, reflecting the fact that it is a normal component of human physiology. The concentration of creatine in breast milk has been measured, and it contributes to the neonate's creatine supply during a period when endogenous synthesis capacity is still developing.</p>

    <p>Whether supplemental creatine increases breast milk creatine concentration and whether this has any effect on the nursing infant are questions that have not been thoroughly studied. As with pregnancy, the biological plausibility of safety is strong (creatine is endogenous and present in breast milk at baseline), but specific supplementation data in breastfeeding women is lacking.</p>

    <h2>Summary</h2>

    <p>Creatine during pregnancy is a research frontier, not a settled question. Animal studies provide compelling evidence that maternal creatine supplementation may protect the fetal brain during birth-related oxygen deprivation. Human observational data supports the biological importance of maternal creatine supply to the developing fetus. However, human clinical trial data on the safety and efficacy of creatine supplementation during pregnancy is insufficient to support a recommendation for or against its use. Pregnant women considering creatine should consult their obstetrician and recognize that this decision involves genuine uncertainty that has not yet been resolved by the research.</p>

    <section>
      <h2>Bibliography</h2>
      <ol>
        <li>Ellery SJ, Walker DW, Dickinson H. Creatine for women: a review of the relationship between creatine and the reproductive cycle and female-specific benefits of creatine therapy. <em>Amino Acids</em>. 2016;48(8):1807-1817. doi:10.1007/s00726-016-2199-y</li>
        <li>Ellery SJ, Ireland Z, Kett MM, Snow R, Walker DW, Dickinson H. Creatine pretreatment prevents birth asphyxia-induced injury of the newborn spiny mouse kidney. <em>Pediatr Res</em>. 2013;73(2):201-208. doi:10.1038/pr.2012.174</li>
        <li>Dickinson H, Ellery S, Ireland Z, LaRosa D, Snow R, Walker DW. Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy. <em>BMC Pregnancy Childbirth</em>. 2014;14:150. doi:10.1186/1471-2393-14-150</li>
        <li>Brosnan JT, da Silva RP, Brosnan ME. The metabolic burden of creatine synthesis. <em>Amino Acids</em>. 2011;40(5):1325-1331. doi:10.1007/s00726-011-0853-y</li>
        <li>Ireland Z, Dickinson H, Snow R, Walker DW. Maternal creatine: does it reach the fetus and improve survival after an acute hypoxic episode in the spiny mouse (Acomys cahirinus)? <em>Am J Obstet Gynecol</em>. 2008;198(4):431.e1-431.e6. doi:10.1016/j.ajog.2007.10.790</li>
        <li>Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. <em>J Int Soc Sports Nutr</em>. 2017;14:18. doi:10.1186/s12970-017-0173-z</li>
      </ol>
    </section>
      
      
      <section class="faq-section">
        <h2>Frequently Asked Questions</h2>
        
        <div class="faq-item">
          <h3>Why Creatine Matters During Fetal Development?</h3>
          <p>The developing fetus has high energy demands, and the creatine-phosphocreatine system plays an important role in fetal metabolism. Creatine is synthesized by the fetus, but fetal synthesis capacity is limited, particularly in early development. The placenta transfers creatine from maternal blood to the fetus, supplementing fetal production.</p>
        </div>
        <div class="faq-item">
          <h3>What is the ellery et al. research program?</h3>
          <p>Stacey Ellery and colleagues at the Hudson Institute of Medical Research in Melbourne, Australia, have led the investigation into creatine and pregnancy. Their research program has progressed from animal models to human observational studies and early clinical work.</p>
        </div>
        <div class="faq-item">
          <h3>What is the dickinson et al. preclinical data?</h3>
          <p>Dickinson et al. (2014) published preclinical research examining the mechanisms of creatine-mediated neuroprotection in fetal development. Their work, published in the Journal of Clinical and Experimental Pharmacology and Physiology, examined creatine supplementation in animal models of birth asphyxia and demonstrated protective effects on multiple organ systems, not only the brain.</p>
        </div>
        <div class="faq-item">
          <h3>What is the human observational data?</h3>
          <p>Observational studies have examined creatine levels in pregnant women and their relationship to pregnancy outcomes. Lower maternal creatine levels have been associated with lower birth weight in some studies. The fetal capacity for creatine synthesis increases throughout gestation but remains limited relative to postnatal capacity, suggesting that maternal supply is physiologically important during pregnancy.</p>
        </div>
        <div class="faq-item">
          <h3>What is the current state of human trials?</h3>
          <p>As of this writing, human clinical trials of creatine supplementation during pregnancy are in early stages. The transition from animal models to human trials requires establishing safety in the pregnant population before efficacy can be assessed. This process is appropriately cautious, as any intervention during pregnancy carries potential risks to both mother and fetus that must be thoroughly evaluated.</p>
        </div>
      </section>
      </article>

      <!-- In-article CTA -->
      <div class="cta-box">
        <h3>Stay Current with Creatinepedia</h3>
        <p>Get notified when new entries are published. No hype, no marketing — just what the science shows.</p>
        <a href="#newsletter" class="cta-button">Get New Entries</a>
      </div>

      <!-- Pillar page link -->
      <div class="related-articles">
        <h3>Read the Full Guide</h3>
        <p style="margin-bottom: 0.75rem;"><a href="/safety/creatine-safety-complete-guide">Complete Safety Guide: Safety & Concerns</a> — comprehensive overview with all cited sources.</p>
      </div>
    </div>

    <!-- Category nav -->
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mt-12">
      <div class="flex items-center justify-between p-5 bg-slate-100 dark:bg-zinc-900/50 border border-slate-200 dark:border-zinc-800/60 rounded-xl">
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-1">Category</p>
          <a href="/safety" class="text-slate-800 dark:text-zinc-200 font-medium hover:text-sky-600 dark:hover:text-sky-400 transition-colors">Safety & Concerns</a>
        </div>
        <a href="/safety" class="text-sm text-sky-600 dark:text-sky-400 font-medium hover:underline">Browse all &rarr;</a>
      </div>
    </div>
  </main>

  <!-- Newsletter section -->
  <section id="newsletter" class="py-16 bg-slate-100 dark:bg-zinc-900/30 border-t border-slate-200 dark:border-zinc-800/60">
    <div class="max-w-xl mx-auto px-6 text-center">
      <h2 class="font-serif text-3xl text-slate-900 dark:text-zinc-100 mb-3">New Entries & Updates</h2>
      <p class="text-slate-600 dark:text-zinc-400 mb-6">New encyclopedia entries and updates — delivered when they matter. No spam. Unsubscribe anytime.</p>
      <form class="flex flex-col sm:flex-row gap-3 justify-center" onsubmit="return false;">
        <input type="email" placeholder="your@email.com" class="px-4 py-3 rounded-lg border border-slate-300 dark:border-zinc-700 bg-white dark:bg-zinc-800 text-slate-900 dark:text-zinc-100 focus:outline-none focus:ring-2 focus:ring-sky-500 w-full sm:w-72">
        <button type="submit" class="px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg transition-colors cta-glow">Subscribe</button>
      </form>
      <p class="text-xs text-slate-500 dark:text-zinc-600 mt-3">100% evidence-based. Every claim cited.</p>
    </div>
  </section>


  <footer class="py-16 border-t border-slate-200 dark:border-zinc-900">
    <div class="max-w-7xl mx-auto px-6">
      <div class="grid grid-cols-2 md:grid-cols-6 gap-8 mb-12">
        <div class="col-span-2 md:col-span-2">
          <div class="flex items-center gap-3 mb-3">
            <div class="w-8 h-8 rounded bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center">
              <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
            </div>
            <span class="text-slate-700 dark:text-zinc-300 font-medium">Creatinepedia</span>
          </div>
          <p class="text-sm text-slate-600 dark:text-zinc-500 mb-6 max-w-xs">The creatine encyclopedia. 100 entries cited from peer-reviewed sources.</p>
          <a href="#newsletter" class="inline-block px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors">New Entries</a>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Research</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science</a></li>
            <li><a href="/dosing" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing</a></li>
            <li><a href="/safety" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Applications</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/sports" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">By Sport</a></li>
            <li><a href="/comparisons" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Comparisons</a></li>
            <li><a href="/quality" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Product Quality</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Guides</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science/creatine-mechanisms-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science Guide</a></li>
            <li><a href="/dosing/creatine-dosing-protocols-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing Guide</a></li>
            <li><a href="/safety/creatine-safety-complete-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety Guide</a></li>
            <li><a href="/quality/creatine-buying-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Buying Guide</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Site</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Home</a></li>
            <li><a href="/articles" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">All Articles</a></li>
            <li><a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Scale With Search</a></li>
          </ul>
        </div>
      </div>
      <div class="pt-8 border-t border-slate-200 dark:border-zinc-900 flex flex-col md:flex-row items-center justify-between gap-4">
        <p class="text-xs text-slate-500 dark:text-zinc-700">&copy; 2026 Creatinepedia. All cited sources are property of their respective authors.</p>
        <p class="text-xs text-slate-500 dark:text-zinc-700">Powered by <a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-sky-500">Scale With Search</a></p>
      </div>
    </div>
  </footer>


  <script>
    // Theme
    if (localStorage.theme === 'light') {
      document.documentElement.classList.remove('dark');
    } else if (localStorage.theme === 'dark' || !('theme' in localStorage)) {
      document.documentElement.classList.add('dark');
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
      document.documentElement.classList.add('dark');
    }

    // Mega menu
    (function() {
      const triggers = document.querySelectorAll('.mega-trigger');
      const panels = document.querySelectorAll('.mega-panel');
      let activePanel = null;
      let closeTimeout = null;

      function openPanel(id) {
        clearTimeout(closeTimeout);
        panels.forEach(p => { p.classList.add('hidden'); });
        triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        const panel = document.getElementById('mega-' + id);
        const trigger = document.querySelector('[data-mega="' + id + '"] .mega-trigger');
        if (panel) { panel.classList.remove('hidden'); activePanel = panel; }
        if (trigger) trigger.setAttribute('aria-expanded', 'true');
      }

      function scheduleClose() {
        closeTimeout = setTimeout(() => {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
          activePanel = null;
        }, 200);
      }

      function cancelClose() { clearTimeout(closeTimeout); }

      triggers.forEach(btn => {
        const wrapper = btn.closest('[data-mega]');
        const id = wrapper.getAttribute('data-mega');
        btn.addEventListener('mouseenter', () => openPanel(id));
        btn.addEventListener('click', (e) => {
          e.preventDefault();
          const panel = document.getElementById('mega-' + id);
          if (panel && !panel.classList.contains('hidden')) {
            panel.classList.add('hidden');
            btn.setAttribute('aria-expanded', 'false');
          } else {
            openPanel(id);
          }
        });
        wrapper.addEventListener('mouseleave', scheduleClose);
      });

      panels.forEach(panel => {
        panel.addEventListener('mouseenter', cancelClose);
        panel.addEventListener('mouseleave', scheduleClose);
      });

      document.addEventListener('click', (e) => {
        if (!e.target.closest('[data-mega]') && !e.target.closest('.mega-panel')) {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });

      document.addEventListener('keydown', (e) => {
        if (e.key === 'Escape') {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });
    })();

    // Mobile menu
    const mobileMenuBtn = document.getElementById('mobile-menu-btn');
    const mobileMenu = document.getElementById('mobile-menu');
    const menuIcon = document.getElementById('menu-icon');
    const closeIcon = document.getElementById('close-icon');
    if (mobileMenuBtn) {
      mobileMenuBtn.addEventListener('click', () => {
        mobileMenu.classList.toggle('hidden');
        menuIcon.classList.toggle('hidden');
        closeIcon.classList.toggle('hidden');
      });
    }

    // Mobile accordion sections
    document.querySelectorAll('.mobile-section-toggle').forEach(btn => {
      btn.addEventListener('click', () => {
        const section = btn.nextElementSibling;
        const chevron = btn.querySelector('svg');
        section.classList.toggle('hidden');
        chevron.style.transform = section.classList.contains('hidden') ? '' : 'rotate(180deg)';
      });
    });
  </script>
</body>
</html>